Search for: "Generic Pharmaceutical Association" Results 61 - 80 of 3,015
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2024, 9:05 pm by Gianna Hill
To approve the new uses, EPA must conduct a detailed review, evaluating the potential risks associated with the proposed use and implementation of restrictions. [read post]
10 Jan 2024, 11:11 am by Roger Bate
The second problem is more practical and is generally considered the most significant problem with accelerated approval. [read post]
8 Jan 2024, 11:59 am by luiza
”  The article also cites research showing that “private equity ownership is associated with higher death rates for patients in nursing homes and increased costs to taxpayers. [read post]
2 Jan 2024, 12:56 pm by Kevin LaCroix
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
20 Dec 2023, 2:50 pm by Cynthia Marcotte Stamer
A Fellow in the American College of Employee Benefit Counsel, Co-Chair of the American Bar Association (“ABA”) International Section Life Sciences and Health Committee and Vice-Chair Elect of its International Employment Law Committee, Chair-Elect of the ABA TIPS Section Medicine & Law Committee, Past Chair of the ABA Managed Care & Insurance Interest Group, Scribe for the ABA JCEB Annual Agency Meeting with HHS-OCR, past chair of the ABA RPTE Employee Benefits &… [read post]
20 Dec 2023, 7:00 am by Searcy Law
Wegovy, a similar drug manufactured by a different pharmaceutical company, became extremely popular as well. [read post]
20 Dec 2023, 7:00 am by Searcy Law
Wegovy, a similar drug manufactured by a different pharmaceutical company, became extremely popular as well. [read post]
20 Dec 2023, 7:00 am by Searcy Law
Wegovy, a similar drug manufactured by a different pharmaceutical company, became extremely popular as well. [read post]
19 Dec 2023, 4:48 pm by Cynthia Marcotte Stamer
The Departments establishment of the IDR fee for post-February 20, 2025 disputes and their previous December 15, 2023 announcement of the full reopening of the IDR portal for all dispute categories are part of the Departments’ ongoing response to the August 3, 2023 Federal District court ruling in Texas Medical Association, et al. v. [read post]
14 Dec 2023, 9:05 pm by William McDonald
The move is part of the EU’s broader attempts to overhaul pharmaceutical laws and encourage drug companies to introduce their products in all EU member states. [read post]
The American Association of Pro-Life Obstetricians and Gynecologists previously filed citizen petitions challenging the use of the drug in 2002 and 2019. [read post]
12 Dec 2023, 10:09 am by Overhauser Law Offices, LLC
Patent Office issued the following 270 patents to persons and businesses in Indiana in October 2023: US 11515057 B2 High optical transparent two-dimensional electronic conducting system and process for generating same US 11515742 B2 Methods, systems, and apparatus for reducing cogging torque in an electric machine US 11512362 B2 Method for producing an ultra high strength galvannealed steel sheet and obtained galvannealed steel sheet US 11514541 B2 Systems and methods for managing a… [read post]
12 Dec 2023, 5:00 am by The Petrie-Flom Center Staff
Tara Davis is an Attorney of the High Court of South Africa and a Senior Associate at Power & Associates. [read post]
8 Dec 2023, 10:02 am by Cynthia Marcotte Stamer
HIPAA Entities Duty To Guard EPHI Against Phishing The HIPAA Privacy Rule and Security Rule require health care providers, heath plans, health care clearinghouses (“Covered Entities”) and their businesses associates (collectively “HIPAA Entities”) to protect EPHI and other protected health information against use, access, disclosure or destruction by third parties except under the conditions allowed by HIPAA. [read post]
4 Dec 2023, 2:01 pm by Tom Lamb
For background, here is a general Syfovre timeline bringing us up to the present time: Syfovre (pegcetacoplan injection) was approved by the FDA in February 2023 as a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD); In July 2023 the first reports of retinal vasculitis associated with Syfovre became public. [read post]
3 Dec 2023, 7:10 pm by Kurt R. Karst
., generics) will be coverable under Part D regardless of the manufacturer’s participation in the Discount Program. [read post]
30 Nov 2023, 8:44 pm by Hyman Phelps McNamara
Walsh is a nationally recognized expert on FDA enforcement matters across all sectors and has held numerous leadership positions with FDLI and with the Women’s White Collar Defense Association. [read post]
30 Nov 2023, 4:23 pm by Michel-Adrien
In particular, AI driven drug discovery is becoming increasingly prevalent as high costs and attrition rates associated with developing new drugs pose significant challenges to the biotech and pharmaceutical industries. [read post]